Loading...
XHKG
0030
Market cap182mUSD
Jun 13, Last price  
0.19HKD
1D
-3.57%
1Q
44.27%
Jan 2017
45.38%
Name

Ban Loong Holdings Ltd

Chart & Performance

D1W1MN
XHKG:0030 chart
No data to show
P/E
79.27
P/S
1.90
EPS
0.00
Div Yield, %
—
Shrs. gr., 5y
6.27%
Rev. gr., 5y
-8.27%
Revenues
755m
-2.17%
41,028,51473,784,184150,249,600108,878,606130,257,679103,409,027115,025,51468,747,91359,965,27556,403,923116,373,626299,259,373767,607,149910,081,9101,162,153,6351,216,714,366179,527,751452,908,674771,655,095754,930,252
Net income
18m
-90.55%
13,130,1027,619,441-5,546,77968,552,356-5,266,108-23,143,67512,554,422-22,258,263-23,453,872-33,579,904-23,470,398-191,218,035-1,465,73544,271,81449,573,53313,207,234-1,117,313,589-168,870,808191,659,91618,120,271
CFO
0k
-100.00%
-10,385,352-6,736,40617,617,2496,382,284-3,462,557-8,114,431-18,450,806-17,195,980-17,568,140-31,490,338-144,795,065-130,843,324-178,054,171-257,476,350-53,564,900-178,681,434-4,479,698-140,980,13161,120,1570
Dividend
Aug 05, 20080.5866 HKD/sh

Profile

Ban Loong Holdings Limited, an investment holding company, engages in the money lending, and trading of goods and commodities in Hong Kong, the People's Republic of China, and internationally. The company operates through Money Lending; Trading of Goods and Commodities; and Cannabidiol (CBD) isolate segments. It provides short-term personal and corporate loans; and trades in refined edible oil, sugar, cosmetic, cannabidiol, and personal care products. Ban Loong Holdings Limited has a strategic cooperation agreement with Alpex Pharma SA to cooperate on the development and commercialization of nutraceutical products. The company was formerly known as ABC Communications (Holdings) Limited and changed its name to Ban Loong Holdings Limited in October 2015. Ban Loong Holdings Limited is based in Wan Chai, Hong Kong.
URL
http://0030.com.hk
IPO date
Oct 09, 1991
Employees
33
Domiciled in
HK
Incorporated in
BM

Valuation

Title
HKD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑03
Income
Revenues
754,930
66.68%
771,655
329.82%
452,909
152.28%
Cost of revenue
728,214
753,129
481,781
Unusual Expense (Income)
NOPBT
26,717
18,526
(28,872)
NOPBT Margin
3.54%
2.40%
Operating Taxes
5,763
3,562
2,956
Tax Rate
21.57%
19.23%
NOPAT
20,953
14,964
(31,828)
Net income
18,120
-110.73%
191,660
-117.15%
(168,871)
-84.89%
Dividends
Dividend yield
Proceeds from repurchase of equity
100,252
BB yield
Debt
Debt current
6,097
34,258
16,369
Long-term debt
16,803
35,344
14,195
Deferred revenue
Other long-term liabilities
1,500
(9,843)
(11,343)
Net debt
(189,592)
(129,738)
(442,152)
Cash flow
Cash from operating activities
61,120
(140,980)
CAPEX
(4,926)
(393)
Cash from investing activities
(4,661)
(289)
Cash from financing activities
(852)
98,839
FCF
(36,798)
(65,106)
(25,841)
Balance
Cash
212,482
199,324
472,699
Long term investments
11
16
17
Excess cash
174,746
160,757
450,071
Stockholders' equity
259,940
(839,596)
(1,038,567)
Invested Capital
99,224
1,128,721
1,179,680
ROIC
3.28%
1.40%
ROCE
9.75%
6.41%
EV
Common stock shares outstanding
8,737,899
8,737,899
6,736,308
Price
0.18
 
Market cap
1,529,132
 
EV
1,339,540
EBITDA
26,717
24,192
(23,300)
EV/EBITDA
50.14
Interest
5,906
Interest/NOPBT